Steven Cohen Intra Cellular Therapies, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 119,862 shares of ITCI stock, worth $10 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

119,862

Previous 554,186 78.37%

Holding current value

$10 Million

Previous $38 Million 76.91%

% of portfolio

0.02%

Previous 0.11%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$67.99 - $80.84 $29.5 Million - $35.1 Million	-434,324 Reduced 78.37%	119,862 $8.76 Million
Q2 2024 Aug 14, 2024	BUY	$64.76 - $79.84 $24.6 Million - $30.4 Million	380,420 Added 218.93%	554,186 $38 Million
Q1 2024 May 15, 2024	BUY	$64.37 - $75.65 $11.2 Million - $13.1 Million	173,766 New	173,766 $12 Million
Q2 2023 Aug 14, 2023	SELL	$54.67 - $66.44 $11.4 Million - $13.9 Million	-209,008 Reduced 89.27%	25,121 $1.59 Million
Q1 2023 May 15, 2023	BUY	$43.8 - $56.99 $1.75 Million - $2.28 Million	39,977 Added 20.59%	234,129 $12.7 Million
Q4 2022 Feb 14, 2023	SELL	$44.07 - $54.45 $20.3 Million - $25.1 Million	-461,648 Reduced 70.39%	194,152 $10.3 Million
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $28 Million - $39.3 Million	655,800 New	655,800 $30.5 Million
Q4 2020 Feb 16, 2021	SELL	$23.34 - $32.22 $13 Million - $17.9 Million	-555,643 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$17.61 - $31.86 $9.78 Million - $17.7 Million	555,643 New	555,643 $14.3 Million
Q4 2019 Feb 14, 2020	SELL	$7.26 - $38.49 $4.06 Million - $21.6 Million	-559,900 Closed	0 $0
Q3 2019 Nov 15, 2019	BUY	$7.47 - $14.03 $1.94 Million - $3.64 Million	259,548 Added 86.41%	559,900 $4.18 Million
Q4 2018 Feb 14, 2019	SELL	$10.36 - $20.96 $3.46 Million - $7 Million	-334,114 Reduced 52.66%	300,352 $3.42 Million
Q3 2018 Nov 14, 2018	BUY	$17.77 - $22.9 $7.9 Million - $10.2 Million	444,609 Added 234.18%	634,466 $13.8 Million
Q2 2018 Aug 14, 2018	SELL	$17.33 - $23.4 $704,239 - $950,905	-40,637 Reduced 17.63%	189,857 $3.36 Million
Q1 2018 May 15, 2018	SELL	$15.16 - $25.49 $3.33 Million - $5.6 Million	-219,506 Reduced 48.78%	230,494 $4.85 Million
Q4 2017 Feb 14, 2018	BUY	$14.27 - $16.79 $2.7 Million - $3.18 Million	189,300 Added 72.61%	450,000 $6.52 Million
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $2.81 Million - $5.76 Million	260,700	260,700 $4.11 Million

Others Institutions Holding ITCI

# of Institutions

378

Shares Held

84.1M

Call Options Held

319K

Put Options Held

143K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account